Back to results
US 2026/0092283 A1Published application
Compositions and methods for the treatment of complications and disorders relating to von willebrand factor
AssigneeBand Therapeutics, LLC
InventorsShuhao Zhu, James C. Gilbert
Life of this patent
Estimating the term…
Abstract
The present invention provides VWF protective agents, including aptamers and antibodies for the treatment and or amelioration of complications or disorders arising from aberrant binding or function of VWF.
Claims14
A polynucleotide that binds to von Willebrand Factor (VWF) comprising:
- a) a sequence corresponding to positions 5-25 of SEQ ID NO.:
- 1, and
- b) 4 or more additional nucleotides at the 5′ end of the sequence and 4 or more additional nucleotides at the 3′ end of the sequence,
- wherein the 4 or more additional nucleotides at the 5′ and 3′ ends are complementary to each other;
- wherein the polynucleotide forms a stable stem-loop structure comprising a double-stranded stem region formed by at least 6 nucleotide pairs at the 5′ and 3′ ends;
- and
- wherein the polynucleotide does not comprise the sequence of SEQ ID NO. 1.
4 more elements
Dependencies are inferred from the claim text.